FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048778639> ?p ?o ?g. }

• W3048778639 endingPage "833" @default.
• W3048778639 startingPage "822" @default.
• W3048778639 abstract "This study examined the effects of sacubitril/valsartan on N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels and determined patient characteristics associated with favorable NT-proBNP reduction response. NT-proBNP levels reflect cardiac wall stress and predict event risk in patients with acute decompensated heart failure (ADHF). Post-hoc analysis of the TRANSITION (Comparison of Pre- and Post-discharge Initiation of Sacubitril/Valsartan Therapy in HFrEF Patients After an Acute Decompensation Event) study, including stabilized ADHF patients with reduced ejection fraction, randomized to open-label sacubitril/valsartan initiation in-hospital (pre-discharge) versus post-discharge. NT-proBNP was measured at randomization (baseline), discharge, and 4 and 10 weeks post-randomization. A favorable NT-proBNP response was defined as reduction to ≤1,000 pg/ml or >30% from baseline. In patients receiving sacubitril/valsartan in-hospital, NT-proBNP was reduced by 28% at discharge, with 46% of patients obtaining favorable NT-proBNP reduction response compared with a 4% reduction and 18% favorable response rate in patients initiated post-discharge (p < 0.001). NT-proBNP was reduced similarly in patients initiating sacubitril/valsartan pre- and post-discharge (reduction at 4 weeks: 25%/22%; 10 weeks: 38%/34%) with comparable favorable response rates (46%/42% and 51%/48% at 4 and 10 weeks, respectively). NT-proBNP favorable response at 4 weeks was associated with lower risk of first heart failure (HF) rehospitalization or cardiovascular death through 26 weeks (hazard ratio: 0.57; 95% confidence interval [CI]: 0.38 to 0.86; p = 0.007). Predictors of a favorable response at 4 weeks were starting dose ≥49/51 mg twice daily, higher baseline NT-proBNP, lower baseline serum creatinine, de novo HF, no atrial fibrillation, angiotensin-converting enzyme inhibitor–naive or angiotensin receptor blocker–naive, and no prior myocardial infarction. In-hospital initiation of sacubitril/valsartan produced rapid reductions in NT-proBNP, statistically significant at discharge. A favorable NT-proBNP response over time was associated with a better prognosis and predicted by higher starting dose and predisposing clinical profile. (Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event [TRANSITION]; NCT02661217)" @default.
• W3048778639 created "2020-08-18" @default.
• W3048778639 creator A5000051431 @default.
• W3048778639 creator A5001100206 @default.
• W3048778639 creator A5001190600 @default.
• W3048778639 creator A5001579932 @default.
• W3048778639 creator A5002002083 @default.
• W3048778639 creator A5002185985 @default.
• W3048778639 creator A5002864049 @default.
• W3048778639 creator A5003321544 @default.
• W3048778639 creator A5003661273 @default.
• W3048778639 creator A5004568691 @default.
• W3048778639 creator A5004646660 @default.
• W3048778639 creator A5006357262 @default.
• W3048778639 creator A5006856029 @default.
• W3048778639 creator A5007031444 @default.
• W3048778639 creator A5007353206 @default.
• W3048778639 creator A5007472769 @default.
• W3048778639 creator A5007608800 @default.
• W3048778639 creator A5009616998 @default.
• W3048778639 creator A5010044406 @default.
• W3048778639 creator A5010519775 @default.
• W3048778639 creator A5012150541 @default.
• W3048778639 creator A5012641937 @default.
• W3048778639 creator A5013069712 @default.
• W3048778639 creator A5013301504 @default.
• W3048778639 creator A5014415439 @default.
• W3048778639 creator A5014666619 @default.
• W3048778639 creator A5015704932 @default.
• W3048778639 creator A5015770064 @default.
• W3048778639 creator A5015794888 @default.
• W3048778639 creator A5016177618 @default.
• W3048778639 creator A5016320226 @default.
• W3048778639 creator A5016752955 @default.
• W3048778639 creator A5017723873 @default.
• W3048778639 creator A5017838649 @default.
• W3048778639 creator A5018986120 @default.
• W3048778639 creator A5021365679 @default.
• W3048778639 creator A5021410184 @default.
• W3048778639 creator A5021694941 @default.
• W3048778639 creator A5022989444 @default.
• W3048778639 creator A5023374021 @default.
• W3048778639 creator A5023398316 @default.
• W3048778639 creator A5023689503 @default.
• W3048778639 creator A5024525502 @default.
• W3048778639 creator A5024633506 @default.
• W3048778639 creator A5025128967 @default.
• W3048778639 creator A5025294303 @default.
• W3048778639 creator A5025555714 @default.
• W3048778639 creator A5025724170 @default.
• W3048778639 creator A5027003368 @default.
• W3048778639 creator A5027287570 @default.
• W3048778639 creator A5027328922 @default.
• W3048778639 creator A5027534019 @default.
• W3048778639 creator A5027682504 @default.
• W3048778639 creator A5028768641 @default.
• W3048778639 creator A5029011660 @default.
• W3048778639 creator A5029589802 @default.
• W3048778639 creator A5030843597 @default.
• W3048778639 creator A5031068867 @default.
• W3048778639 creator A5031595804 @default.
• W3048778639 creator A5031874851 @default.
• W3048778639 creator A5034871729 @default.
• W3048778639 creator A5035109308 @default.
• W3048778639 creator A5036752495 @default.
• W3048778639 creator A5037030871 @default.
• W3048778639 creator A5037170080 @default.
• W3048778639 creator A5038733042 @default.
• W3048778639 creator A5039262846 @default.
• W3048778639 creator A5039330490 @default.
• W3048778639 creator A5039597665 @default.
• W3048778639 creator A5040021014 @default.
• W3048778639 creator A5040100524 @default.
• W3048778639 creator A5040848081 @default.
• W3048778639 creator A5042163996 @default.
• W3048778639 creator A5042673494 @default.
• W3048778639 creator A5042865197 @default.
• W3048778639 creator A5043587781 @default.
• W3048778639 creator A5044987866 @default.
• W3048778639 creator A5045034448 @default.
• W3048778639 creator A5046758219 @default.
• W3048778639 creator A5047640248 @default.
• W3048778639 creator A5048590230 @default.
• W3048778639 creator A5048860855 @default.
• W3048778639 creator A5049579709 @default.
• W3048778639 creator A5050140282 @default.
• W3048778639 creator A5050423418 @default.
• W3048778639 creator A5050868282 @default.
• W3048778639 creator A5051241194 @default.
• W3048778639 creator A5051556655 @default.
• W3048778639 creator A5051759363 @default.
• W3048778639 creator A5052178369 @default.
• W3048778639 creator A5052929820 @default.
• W3048778639 creator A5053049259 @default.
• W3048778639 creator A5053497083 @default.
• W3048778639 creator A5055463163 @default.
• W3048778639 creator A5055704659 @default.
• W3048778639 creator A5055741201 @default.

• next